Anthem Biosciences (ANTHEM) Share Price Falls 2.05%: What Changed Today
- October 1, 2026
- Posted by: Kunal Singla
- Category: News
Anthem Biosciences Share Price is trading at Rs 830.65 after a 2.05% decline today, with market capitalisation at Rs 49,046.66 Cr. According to Univest data, the stock is in its third consecutive session of decline, and the cumulative fall from Rs 883.1 is 5.94%. The move keeps Anthem Biosciences Share Price in focus for traders tracking Anthem Biosciences Share Price Today, Anthem Biosciences Stock News and Anthem Biosciences Share Price Fall. What the price data shows is simple: the stock opened at Rs 848.05, touched a high of Rs 851 and a low of Rs 830.65, and is last traded at the day’s low. The latest Univest figures do not establish a company-specific catalyst, so the main reading today comes from the price move itself, the valuation profile and the sector comparison.
Anthem Biosciences (ANTHEM) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 830.65 |
| Previous Close | Rs 848.05 |
| Today's Move | -Rs 17.40 (-2.05%) |
| Open | Rs 848.05 |
| High | Rs 851 |
| Low | Rs 830.65 |
| Market Capitalisation | Rs 49,046.66 crore |
| Market Cap Category | Large Cap |
Anthem Biosciences Share Price is at Rs 830.65 versus the previous close of Rs 848.05, a day change of Rs -17.4 and a day change percent of -2.05%. The stock opened at Rs 848.05, moved to an intraday high of Rs 851 and then touched a low of Rs 830.65, which is also the current price. That keeps the stock near the lower end of the day’s range. With a market capitalisation of Rs 49,046.66 Cr, Anthem Biosciences is a Large Cap name, so each percentage move carries meaningful weight in the day’s market update. In the context of Anthem Biosciences Share Price Today, the third consecutive session of decline matters more than the single session alone because the cumulative streak change is -5.94% from Rs 883.1. For readers following Anthem Biosciences Share Price Live, the key point is that the stock is trading below the prior close and has not reclaimed the opening level. That sets up the next question around valuation and operating context.
Anthem Biosciences (ANTHEM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 49,046.66 crore |
| P/E Ratio | 82.98x |
| P/B Ratio | 15.27x |
| ROE | 21.98% |
| ROCE | 29.62% |
| EPS | Rs 10.22 |
| Book Value Per Share | Rs 55.53 |
| Dividend Yield | 0.24% |
Anthem Biosciences (ANTHEM) fundamental metrics show P/E 82.98x, P/B 15.27x, ROE 21.98%, ROCE 29.62%. These ratios show where the company stands today and are not a call to buy or sell.
Anthem Biosciences has a market capitalisation of Rs 49,046.66 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 82.98x, P/B at 15.27x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 21.98% and ROCE of 29.62%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 10.22, book value per share of Rs 55.53, dividend yield of 0.24%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.35x, median ROE of 11.61%, median ROCE of 13.46%. Together they describe the fundamental backdrop without implying a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 82.98x |
| Benchmark Median P/E | 31.35x |
| Benchmark Average P/E | 46.92x |
| Benchmark P/E Range | 3.13x to 654.72x |
| Company P/B Ratio | 15.27x |
| Benchmark Median P/B | 2.84x |
| Benchmark Average P/B | 4.25x |
| Company ROE | 21.98% |
| Benchmark Median ROE | 11.61% |
| Benchmark Average ROE | 10.43% |
| Company ROCE | 29.62% |
| Benchmark Median ROCE | 13.46% |
| Benchmark Average ROCE | 13.3% |
| Company Market Capitalisation | Rs 49,046.66 crore |
| Benchmark Median Market Cap | Rs 827.89 crore |
| Benchmark Average Market Cap | Rs 13,758.85 crore |
Anthem Biosciences (ANTHEM) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Anthem Biosciences (ANTHEM) has a P/E ratio of 82.98x, which is above the benchmark median of 31.35x, a difference of +164.69%. A P/E difference of this kind is a reference point rather than a recommendation.
Anthem Biosciences (ANTHEM) has a ROE of 21.98%, which is above the benchmark median of 11.61%, a difference of +89.32%. Anthem Biosciences (ANTHEM) has a ROCE of 29.62%, which is above the benchmark median of 13.46%, a difference of +120.06%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,24,466.35 | 34.69 | 4.85 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,46,222.11 | 81.95 | 13.57 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,76,300.5 | 80.12 | 19.47 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,12,817.68 | 24.84 | 4.16 | 19.69 | 21.39 |
| Laurus Labs | LAURUSLABS | 1,10,823.44 | 100.61 | 19.51 | 18.31 | 18.2 |
Anthem Biosciences (ANTHEM) has a P/E ratio of 82.98x compared with the displayed peer median of 80.12x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 21.98% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 29.62% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Anthem Biosciences (ANTHEM) has a market capitalisation of Rs 49,046.66 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Anthem Biosciences
- Anthem Biosciences Share Price is down 2.05% today and is trading near the day’s low.
- The stock is in a third consecutive session of decline, with a cumulative fall of 5.94% from Rs 883.1.
- Anthem Biosciences Fundamental Analysis shows ROE of 21.98% and ROCE of 29.62%, both strong versus the same-industry benchmark.
- The valuation remains elevated, with P/E at 82.98 and P/B at 15.27.
- Healthcare and Pharmaceuticals & Drugs peers show mixed valuation and return profiles, keeping Anthem Biosciences Share Price in comparison focus.
About Anthem Biosciences
Anthem Biosciences operates in Healthcare and the Pharmaceuticals & Drugs industry. The company is positioned as a Large Cap name with a market capitalisation of Rs 49,046.66 Cr. From the verified financial ratios, the business is being valued as a premium pharmaceutical company, supported by high return metrics and a sizeable market presence. Anthem Biosciences Stock News, Anthem Biosciences Latest News and Anthem Biosciences Company News will typically matter most when price action, valuation and sector comparison move together, as they do in today’s Anthem Biosciences Share Price review.
Track Anthem Biosciences Share Price on Univest
Use Anthem Biosciences (ANTHEM) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
You can track Anthem Biosciences Share Price on Univest for live price updates, key fundamental ratios, 52-week levels and market insights in one place. The same page also helps readers follow Anthem Biosciences Stock Analysis, Anthem Biosciences Share Price Today and broader market context without switching between sources. For investors comparing Anthem Biosciences Share Price News and sector peers, Univest keeps the current snapshot easy to review.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Anthem Biosciences Share Price falling today?
Ans. Anthem Biosciences Share Price is down 2.05% to Rs 830.65 today. The price move is confirmed in Univest data; a company-specific reason has not been established. The previous close was Rs 848.05.
What is the current Anthem Biosciences Share Price?
Ans. Anthem Biosciences Share Price is trading at Rs 830.65. The previous close was Rs 848.05, so the stock is lower by Rs 17.4 in today’s market update. The stock moved 2.05% lower during the session.
How much has Anthem Biosciences Share Price moved today?
Ans. Anthem Biosciences Share Price has fallen by 2.05% today. The stock opened at Rs 848.05, touched a high of Rs 851 and a low of Rs 830.65 during the session.
What do Anthem Biosciences valuation ratios show?
Ans. Anthem Biosciences has a P/E of 82.98 and P/B of 15.27. Those levels are above the same-industry median and average, indicating a premium valuation in current Univest data. The relevant peer median P/E is 31.35x.
How strong are Anthem Biosciences profitability ratios?
Ans. Anthem Biosciences shows ROE of 21.98% and ROCE of 29.62%. Both are above the same-industry benchmark median and average, which supports the stock’s premium pricing profile. The relevant peer median ROE is 11.61%.
What are the EPS, book value and dividend yield for Anthem Biosciences?
Ans. Anthem Biosciences reports EPS of Rs 10.22, book value of Rs 55.53 and dividend yield of 0.24%. These figures help frame Anthem Biosciences Share Price against accounting value and payout history.
How does Anthem Biosciences compare with peers?
Ans. Anthem Biosciences trades at a higher P/E than Sun Pharma and Zydus Lifesciences, and near Divi’s Laboratories and Torrent Pharmaceuticals. Its ROE and ROCE are also strong versus several listed peers.
Should investors track Anthem Biosciences Share Price on Univest?
Ans. Yes. Univest tracks Anthem Biosciences Share Price, valuation ratios, market capitalisation and benchmark context together. That makes it easier to follow Anthem Biosciences Stock News and price action in one view.
